Gut Permeability Assessment in Celiac and Gluten Sensitive Children
NCT02690532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2018-08-15
Summary
This study will assess the effect of gluten on gut barrier function. Investigators at the Mayo Clinic have developed a new gut permeability test using rhamnose (sugar \& water solution), and are hoping to prove its effectiveness in a clinical setting.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Imad Absah, MD · Mayo Clinic
Eligibility
- Min Age
- 2 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2018-07-01
- Completion
- 2018-08-01
Countries
- United States
Study Locations
More Related Trials
-
Immune Response in Celiac Disease on In-vitro Gluten Challenge
NCT01909050 ·Status: COMPLETED
-
Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance
NCT03152279 ·Status: COMPLETED
-
Intestinal Permeability, Nutritional Status and Quality of Life in Celiac Disease
NCT04351828 ·Status: COMPLETED
-
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
NCT06324539 ·Status: RECRUITING
-
Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients
NCT02389062 ·Status: COMPLETED ·Phase: NA
-
Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease
NCT03462979 ·Status: SUSPENDED ·Phase: NA
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
The Effect of Gluten on Gut Microbiome and Metabolic Health.
NCT01719913 ·Status: COMPLETED ·Phase: NA
-
Fluorescence Spectroscopy for Gut Permeability Assessment
NCT03434639 ·Status: UNKNOWN
-
Serum Markers in Gluten Challenge
NCT00931892 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
NCT00492960 ·Status: COMPLETED ·Phase: PHASE2
-
Latiglutenase as a Treatment for Celiac Disease
NCT03585478 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of CCX282-B in Patients With Celiac Disease
NCT00540657 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study of Undiagnosed Celiac Disease
NCT01317914 ·Status: COMPLETED ·Phase: NA
-
Impact of Gluten Contamination in Celiac Patients Clinically Responsive and Unresponsive to the Gluten-free Diet
NCT05066191 ·Status: UNKNOWN
-
A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease
NCT03521180 ·Status: COMPLETED
-
Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease?
NCT00175760 ·Status: COMPLETED
-
Virtual Celiac Symptoms Study in Adults and Teenagers
NCT05309330 ·Status: COMPLETED
-
Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome
NCT01094041 ·Status: COMPLETED ·Phase: NA
-
Glutenfree, Gut Microbiota and Metabolic Regulation
NCT05135923 ·Status: COMPLETED ·Phase: NA
-
Assessment of Coeliac Disease in Patients With Type 2 Diabetes
NCT06283264 ·Status: NOT_YET_RECRUITING
-
Effect of AN-PEP Enzyme on Gluten Digestion
NCT01335503 ·Status: COMPLETED ·Phase: NA
-
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
NCT05353985 ·Status: COMPLETED ·Phase: PHASE2
-
Celiac Disease Screening
NCT01902368 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
NCT01560169 ·Status: COMPLETED